Before a congressional hearing on the industry even began, six of the 57 groups — known as organ procurement organizations, or OPOs — announced that they were withdrawing from their own trade group, the Association of Organ Procurement Organizations. In a news release, they cited AOPO’s “lobbying against lifesaving reforms” being implemented by the federal government, and said they wanted to provide clearer information on waste and mismanagement in their ranks.